Compare equities side by side
Stocks breaking to new annual highs
S&P 500 oversold value screener
Relative strength momentum leaders
Upcoming earnings dates & reports
Filter and sort all 500 stocks
Today's biggest gainers and losers
Visual sector performance
Xeriant, Inc. operates in the aerospace and defense sector with highly distressed financials indicating either a pre-revenue development-stage company or a business undergoing significant restructuring. The extreme valuation metrics (104x P/S, negative book value, -18.6% FCF yield) combined with minimal revenue and negative operating cash flow suggest a company burning capital while developing products or capabilities for defense/aerospace applications. Recent 52% three-month rally indicates speculative interest, potentially tied to contract announcements or defense budget developments.
Given near-zero revenue with aerospace/defense classification, Xeriant likely operates as a development-stage company pursuing government contracts, specialized component manufacturing, or defense technology applications. The negative operating cash flow and minimal current ratio (0.02) indicate the company is consuming capital faster than generating revenue, typical of firms in prototype development, certification processes, or awaiting contract awards. The 1038% ROA anomaly combined with negative equity suggests unusual balance sheet structure, possibly from asset write-ups, debt restructuring, or reverse merger activity. Pricing power and competitive advantage cannot be assessed without established revenue streams.
Defense contract award announcements or prime contractor selection for specific programs
Federal defense budget appropriations and authorization bills affecting relevant programs
Product certification milestones (FAA approval for aerospace components, military qualification testing)
Partnership or acquisition announcements with established defense primes (Lockheed, Northrop, Boeing)
Quarterly cash burn rate and runway extension through financing or dilution events
Defense budget sequestration or appropriations delays could eliminate funding for programs Xeriant targets, particularly for developmental or non-critical systems
Technological obsolescence risk if competing solutions (alternative materials, manufacturing processes, or digital systems) emerge before Xeriant achieves production scale
Regulatory certification delays (FAA for aerospace, military qualification for defense) can extend time-to-revenue by years, exhausting capital runway
Established defense primes (Lockheed Martin, Northrop Grumman, Raytheon) possess vertical integration advantages, customer relationships, and can replicate emerging technologies once proven
Well-capitalized venture-backed competitors in defense tech space (Anduril, Shield AI, others) have multi-year runways to outspend on R&D and customer acquisition
Liquidity crisis risk: 0.02 current ratio indicates inability to cover short-term obligations without immediate capital raise or asset sale
Negative equity position (-1.2x P/B) suggests accumulated deficits exceed asset base, limiting borrowing capacity and increasing dilution risk in future financings
Debt/equity of -0.30 with negative equity creates ambiguous capital structure, potentially indicating off-balance-sheet obligations or complex financing arrangements
Going concern risk: negative operating cash flow with minimal revenue suggests company may not survive 12 months without successful financing
low - Defense spending exhibits counter-cyclical or acyclical characteristics, driven by geopolitical threats and multi-year budget authorizations rather than GDP growth. However, development-stage companies face higher financing risk during economic downturns when risk capital becomes scarce. Commercial aerospace exposure (if any) would be highly cyclical, tied to airline capital expenditure cycles and aircraft production rates.
Rising interest rates create significant headwinds for pre-revenue companies through multiple channels: higher discount rates compress valuations of distant cash flows, tighter financial conditions reduce access to growth capital, and opportunity cost increases as investors rotate to safer fixed income. The company's negative equity and minimal current ratio suggest refinancing risk if rates remain elevated. Defense contract revenue (once established) would be relatively rate-insensitive.
Critical exposure given 0.02 current ratio and negative operating cash flow. The company requires ongoing access to capital markets or credit facilities to fund operations. Tightening credit conditions (widening high-yield spreads) would severely constrain ability to raise capital, potentially forcing dilutive equity raises or operational curtailment. Defense contractors typically require working capital facilities to bridge contract payment cycles.
momentum/speculative - The 52% three-month rally despite deteriorating fundamentals attracts short-term traders betting on contract announcements or acquisition speculation. Not suitable for value investors (negative book value), growth investors (no revenue growth to model), or dividend investors (no cash generation). Typical holders would be retail speculators, distressed/special situations funds, or sector-focused investors with high risk tolerance betting on binary outcomes.
high - Pre-revenue aerospace/defense stocks exhibit extreme volatility driven by binary contract outcomes, financing events, and low float. The -46.7% one-year return followed by 52% three-month rally demonstrates characteristic boom-bust pattern. Expect continued high beta (likely >2.0) and susceptibility to sector rotation and risk-on/risk-off sentiment shifts.
